Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
JCO Precision Oncology|March 21, 2024
Two Germline Pathogenic Variants in Cancer Susceptibility Genes and Their Null Implication in Breast Cancer Pathogenesis: The Importance of Tumoral Homologous Recombination Deficiency TestingAlejandra Rezqallah, Sara Torres-Esquius, Alba Llop-Guevara, et al.
Pathologie (Heidelberg, Germany)|January 11, 2023
[Clinically relevant molecular pathological diagnostics in breast cancer]Fiona R Rodepeter, Julia Teply-Szymanski, Marcel Romey, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 10, 2024
Systematic Analysis of Homologous Recombination Deficiency Testing in Ovarian Cancer-Development of Recommendations for Optimal Assay PerformanceMarcel Romey, Fiona Rodepeter, Akira Hattesohl, et al.
The Journal of Molecular Diagnostics : JMD|October 3, 2022
Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort: Validation of Decentralized Genomic ProfilingCarsten Denkert, Marcel Romey, Brad Swedlund, et al.
Cancers|April 27, 2024
NGS-Guided Precision Oncology in Breast Cancer and Gynecological Tumors-A Retrospective Molecular Tumor Board AnalysisNiklas Gremke, Fiona R Rodepeter, Julia Teply-Szymanski, et al.
Cancers|September 23, 2022
Combined Focused Next-Generation Sequencing Assays to Guide Precision Oncology in Solid Tumors: A Retrospective Analysis from an Institutional Molecular Tumor BoardThomas S Tarawneh, Fiona R Rodepeter, Julia Teply-Szymanski, et al.
JAMA Network Open|April 22, 2024
Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian CancerSara Torres-Esquius, Alba Llop-Guevara, Sara Gutiérrez-Enríquez, et al.
NPJ Precision Oncology|July 11, 2026
Comprehensive clinical cancer analysis of homologous recombination deficiency biomarkers in an academic molecular profiling programHeura Domènech, Sara Simonetti, Paula Romero-Lozano, et al.
Cancer Genetics|April 8, 2026
Optimized precision oncology through implementation of a comprehensive molecular analysis pipeline - relevance for additional therapeutic optionsNuwar Harb, Marcel Romey, Albert Grass, et al.
Pageof 1